Cbd dosage guidelines
Pro Research Analysisby 
Searched over 200M research papers
CBD Dosage Guidelines: Safety, Efficacy, and Individualization
Recommended Safe Daily CBD Dosage for Adults
Recent risk assessments suggest that a safe daily dose of CBD for adults is around 10–15 mg per day, based on human and animal studies that focus on liver toxicity and other safety concerns. Regulatory bodies have used a Lowest-Observed-Adverse-Effect Level (LOAEL) from human data to recommend a health-based guidance value of 10 mg/day, while animal studies suggest a slightly higher threshold, translating to about 15 mg/day for humans. These values are especially important given the unregulated nature of many CBD products on the market and the potential for mislabeled dosages .
Clinical Evidence for Therapeutic CBD Doses
Clinical trials and systematic reviews show that therapeutic effects of CBD, such as reduced anxiety and anti-addiction benefits, are more consistently observed at higher doses—typically 300–400 mg per day. Doses below 300 mg/day have shown less consistent or marginal benefits for conditions like insomnia, neurological disorders, and chronic pain. Importantly, increasing the dose from 60 to 400 mg/day does not appear to significantly increase adverse effects, suggesting a relatively wide safety margin at these higher doses in clinical settings 289.
Real-World Self-Dosing Patterns
Observational studies of long-term CBD users in the United States reveal that most people self-administer daily doses ranging from 8 to 390 mg, with an average around 53 mg/day. Users most commonly take CBD for chronic pain, anxiety, and sleep issues. Many report improvements in general health and symptom severity, and some reduce their use of over-the-counter and prescription medications as their symptoms improve with CBD use .
Dosing in Specific Medical Contexts
For epilepsy, especially in children and adults with treatment-resistant forms, clinical studies have used much higher doses—often around 10–50 mg/kg/day (which can be several hundred milligrams per day for adults). These higher doses are associated with better seizure control, and there is a clear linear relationship between dose, blood levels of CBD, and clinical response 46.
For anxiety and related disorders, studies have used a wide range of doses, from as low as 6 mg to as high as 400 mg per dose. Most studies report improved clinical outcomes with minimal side effects, but there is no consensus on an optimal dose, and more standardized research is needed 89.
Individual Variation and Administration Methods
Large-scale studies show that predicting the optimal CBD dose for an individual is difficult, as factors like gender, employment status, and method of administration (inhalation vs. sublingual oil) do not reliably predict final stable doses. This supports the need for a highly individualized approach to CBD dosing, with careful titration based on personal response and tolerance .
Animal Studies and Safety
Animal studies, including those in dogs and mice, indicate that doses up to 10 mg/kg are well tolerated, with minimal adverse effects observed even at higher doses. These findings support the relative safety of CBD, but also highlight the need for more research to determine optimal dosing for specific conditions and species 510.
Conclusion
CBD dosage guidelines vary widely depending on the intended use, individual response, and product formulation. For general safety, a daily dose of 10–15 mg is recommended for adults, while therapeutic effects for conditions like anxiety and epilepsy may require much higher doses (up to several hundred milligrams per day). Most users self-administer doses in the 8–390 mg/day range, often with perceived health benefits and minimal side effects. Because individual responses vary, CBD dosing should be personalized and titrated carefully, with attention to safety and efficacy. More robust clinical trials are needed to establish standardized dosing protocols for different health conditions.
Sources and full results
Most relevant research papers on this topic